Tobramycin, an aminoglycoside antibiotic, has proved to be a useful agent in the treatment of serious infections due to gram-negative microorganisms (6, 13) . Because tobramycin is mainly excreted in the urine, accumulation and consequent toxicity can result in patients with impaired renal function (7) . The low therapeutic index and the rather unpredictable serum levels, even in patients with normal renal function, require accurate monitoring of the serum concentration during therapy (4, 14) .
Several methods for assays of antibiotics have been developed recently, including a fluorescence immunoassay (FIA), a radioimmunoassay (RIA), an enzyme multiplied immunoassay technique, and chemical assays with gas-liquid chromatography and high-performance liquid chromatography (HPLC) (1-3, 5, 8, 10-12, 15, 16, 22) .
Traditionally, assays of antibiotics are performed by a bioassay technique (19, 20) . This method has proved to be reliable and simple; no special equipment is required. Attendant with the use of the bioassay is the delay time (i.e., the time between obtaining the serum sample and getting the results available) of at least 4 h and the lack of specificity (the interference of coadministered antibiotics).
The increasing number of different antibiotic assays justified the present study in which the FIA and the RIA (commercially available kits) were compared with the conventional microbiological assay (MA) and the chemical assay involving HPLC as developed in our laboratory.
The results obtained with each assay were analyzed in terms of usefulness, reproducibility, and cost-effectiveness.
MATERIALS AND METHODS Serum samples collected from patients receiving tobramycin alone (n = 30) or in combination with other antibiotics (n = 18) were stored at -20°C until tested. Standard concentrations were made by a twofold dilution of the stock solution (32 ,ug/ml in distilled water in pooled human sera obtained from healthy volunteers). All assays were performed in duplicate. Dilutions were made with adjustable pipetters (Pipetman Gilson). Tobramycin (potency, 95.6%) was a generous gift of Eli Lilly & Co.
MA. The MA was performed by an agar diffusion method (3) with large bioassay plates (Nunc bio assay disk PS SI) and ISO sensitest agar (Oxoid). Klebsiella edwardsii subsp. atlantae (NCTC 10896) was used as the test organism.
Wells of 7-mm diameter were filled with standard and patient sera in duplicate. After incubation for 4 h at 42°C the diameters of zones of growth inhibition were measured (20) .
FIA. The FIA (AMES, therapeutic drug assay) uses the principle of the competitive protein binding method to measure the antibiotic concentration in the serum samples. Competitive binding reactions are set up with a constant amount of the fluorogenic tobramycin reagent (nonfluorescent under the conditions of the assay), a limiting amount of antibody against tobramycin, and the serum sample.
The tobramycin in the serum sample competes with the fluorogenic tobramycin reagent for the antibody binding sites. The fluorogenic tobramycin reagent, not bound to antibody, is hydrolyzed by P-galactosidase to produce a fluorescent product. The fluorescence produced is proportional to the tobramycin concentration in the serum samples.
The fluorescence was measured with a Perkin Elmer spectrofluorometer (type 1000 M). Reagent preparations, storage, and specimen handling were as described by the manufacturer's instructions.
RIA. The RIA is based upon the competition be- the Nuclear Medical Systems RIA (RIA-NMS) were tested. The differences in procedure of the assays used were limited to minor differences in volume and dilutions of the serum samples (2.3 ml of serum diluted 1:200 and 0.5 ml of serum diluted 1:100) and shorter incubation time at room temperature (10 min versus 40 min). The procedure followed that described in the manufacturer's manual. HPLC. HPLC involves a sample preparation by a combined extraction-deproteinization procedure, followed by postcolumn derivatization, separation by reversed phase chromatography, and measurement of the fluorescent product.
The sample preparation was as follows: 400 ,lI of phenol solution and 700 ,ul of trichloroacetic acid (0.25 mol) were added to 400 RIl of serum. After blending in a Vortex mixer, the mixture was centrifuged for 6 min at 10,000 rpm, and the supernatant was injected by using a Valco valve with a 2-pI injection loop.
An SP 3500 B pump (Spectra Physics) was used to deliver the mobile phase. A Schoeffel model 970 fluorometer (Schoeffel Instrument Corp., Westwood, N.J.) was used to detect fluorescent products, formed by continuous flow, postcolumn derivatization with ortho-phthalaldehyde. Fluorescence excitation was at 340 nm, a KV 418 filter was used for emission, and the photomultiplier voltage was 420 V.
Ortho-phthalaldehyde was supplied by a tube Minipulse-2 pump (Meyvis) with a flow rate of about 0.5 ml/min by using isoversinic tubes (these tubes are specially made for use with aggressive reagents). Outlets from the HPLC column and tube pump were connected with a low dead-column T-piece (Chrompack).
A reaction coil consisting of a stainless steel coil (1.0 m by 0.25-mm ioner diameter) was used between the T-piece and the detector. Analysis was performed by using a lichosorb 5 RP 8 15-cm column (Chrompack). The detector signal was recorded by a Vitatron recorder.
Derivatizing reagent (ortho-phthalaldehyde). Boric acid (24.7 g) was dissolved in 950 ml of water, adjusted to pH 10.4 with 8 N sodium hydroxide solution (320 g/ liter), and diluted to 1,000 ml. To 250 ml of this solution ortho-phthalaldehyde reagent (150 mg dissolved in 5 ml methanol) and 0.5 ml of 2-mercaptoethanol were added. After filtration the reagent was stored at 4°C and used within 1 week. Phenol solution. Phenol (100 g) was dissolved in 6 ml of water. After the addition of 25 ml of dichloromethane the mixture was blended in a Vortex mixer and stored in a dark place at room temperature.
Chromatographic eluent. (Fig. 2) . A straight line was obtained with the MA and the HPLC. The data with the RIA assays yielded a sigmoid shaped curve, but on logit-logit paper the curve was converted into a straight line.
Intra-assay variations. The reproducibility of each assay has been assessed by calculating the coefficient of variation and the standard deviation of the duplicate measurements of the patient sera ( Table 1 ). The lowest coefficient of variation and standard deviation were obtained with the HPLC (coefficient of variation, 9.0%; standard deviation, 0.22 jig/ml) followed in increasing order by the FIA, RIA-DPC, MA, and RIA-NMS.
Inter-assay variations. A comparison between the different assays has been made by calculating the coefficient of correlation, with the MA and the HPLC as the reference methods (Table  1) . When sera of patients receiving tobramycin alone (n = 30) were included in the calculation, correlation coefficients from 0.74 (RIA-DPC and MA) to 0.98 (HPLC and MA) were obtained. The presence of other antibiotics resulted in a decrease of the r values to 0.65, at least when the MA was used as the reference method. The regression analysis of the different assays is given in Fig. 3 Fig. 3 (Fig. 3) . more quickly another method such as FIA, RIA, or HPLC must be used. The inaccuracy of the RIA-DPC argued, at least for the RIA assays tested, in favor of the RIA-NMS.
The set-up time (i.e., the time needed to perform the assay) for one sample, using the FIA and the RIA-NMS, was 50 and 90 min, respectively (Table 4 ). Up to 20 samples could be tested within the same time. Using the HPLC the set-up time of 30 min included 10 min for the sample preparation (i.e., the extraction-deproteinization procedure) and 20 min of retention time. Several samples could be prepared at the same time, but for each additional sample tested, the 20 min more of retention time was required. Despite the simplification of the HPLC method we developed in terms of the combined extraction-deproteinization procedure, the retention time of 20 min was the limiting factor for the number of sera which could be tested daily.
Only 25 sera could be tested each day: 20 patient sera and five standards.
In making a cost analysis of the different methods one has to take into account the price of the commercially available kits and the set-up of the laboratory, as workload, staff experience, labor cost and equipment available.
The workload within the shelf life of the solutions necessary for the different methods as well as the daily workload are important. The shelf life of the solutions of the FIA, RIA-DPC, and RIA-NMS, each of them suitable for 100 assays, was 8, 6 , and 4 weeks, respectively. (21, 24) .
In this regard it is important to note that with a daily workload of 20 patient samples the HPLC cannot be used for other purposes. In making a decision on which method a laboratory should choose, not only are the characteristics of each method important, but also (even more) the number of sera tested daily, the set-up of the laboratory, and the use of the VOL. 15, 1982 */Y//~~~~~/ X///~~~~~~~. 
